5.48% 0.085

비보스 테라퓨틱스 (VVOS)

개요 뉴스 가격 이력 Financials 토론 예측 주식 분할

Vivos Therapeutics Inc (VVOS) 재무 분석

*모든 숫자는 백만 단위입니다.

기간 종료일	2025-03-31	2024-06-30	2024-03-31
기간	3개월	3개월	3개월
Revenues	25.60% 3.016	4.054	3.419
Cost Of Revenue	7.41% 1.507	1.403	0.10
Gross Profit	43.08% 1.509	2.651	1.937
Operating Expenses	18.31% 5.427	4.587	5.722
Benefits Costs and Expenses	14.97% 6.88	5.984	7.182
Costs And Expenses	14.97% 6.88	5.984	7.182
Depreciation and Amortization	22.07% 0.177	0.145	0.146
Operating Income/Loss	102.38% -3.918	-1.936	-3.785
Income/Loss From Continuing Operations Before Tax	100.21% -3.864	-1.93	-3.763
Income/Loss From Continuing Operations After Tax	100.21% -3.864	-1.93	-3.763
Net Income/Loss	100.21% -3.864	-1.93	-3.763
Preferred Stock Dividends And Other Adjustments	-	-	-
Attributable To Noncontrolling Interest	-	-	-
Basic Average Shares	166.24% 8.5953	3.2284	2.3082
Diluted Average Shares	166.24% 8.5953	3.2284	2.3082
Basic Earnings Per Share	25.00% -0.45	-0.60	-1.63
Diluted Earnings Per Share	25.00% -0.45	-0.60	-1.63
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic	-	-	-

ZBH

$96.49

1.38%

STE

$249.29

2.04%

DXCM

$69.89

7.33%

PHG

$31.17

0.73%

GEHC

$81.31

3.47%

$76.92

0.48%